-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Outlook Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2015 to 2023.
- Outlook Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$19.6M, a 7.83% decline year-over-year.
- Outlook Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$61.3M, a 12.1% decline year-over-year.
- Outlook Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$53.1M, a 15.8% increase from 2022.
- Outlook Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$63.1M, a 21.9% decline from 2021.
- Outlook Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$51.7M, a 40.4% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)